Physician profile
Michael Joseph Eblan
NPI 1962795773
$1,352.86
in general payments reported to CMS, 2019-2025
9 companies · $755 in 2025
The $755 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.64 · 2020: $39.20 · 2021: $33.27 · 2022: $186 · 2023: $255 · 2024: $18.88 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $531.34 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $277.84 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Palette Life Sciences, INC. | $163.31 | 2022 | |
| Novocure INC. | $110.90 | 2019-2022 | |
| Sirtex Medical INC | $109.99 | 2023 | Sir-Spheres Microspheres |
| Siemens Medical Solutions USA, INC. | $94.27 | 2025 | Truebeam |
| Angiodynamics, INC. | $37.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.88 | 2025 | |
| Tactile Systems Technology INC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eblan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.